| SODIUM OXYBATE | None | ||
| 4500MG, 6000MG, 7500MG, 9000MG |
Less Than $1000 mn
|
||
| None | None | ||
| None | None | ||
| None | None | ||
| LUMRYZ is a central nervous system depressant indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy | |||
|
Yes
| |||
| LUMRYZ | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 | Patent 13 | Patent 14 | Patent 15 | Patent 16 | Patent 17 | Patent 18 | Patent 19 | Patent 20 | Patent 21 | Patent 22 | Patent 23 | Patent 24 | Patent 25 | Patent 26 | Patent 27 | Patent 28 | Patent 29 | Patent 30 | Patent 31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| *** ********* | |||||||||||||||||||||||||||||||
| ******** ******* *****-*************** ************ ****** ******** **************** | ******** ******* *****-*************** ************ ****** ******** **************** | *****-*************** ************ ****** ******** **************** ** *** *** ***** | ******** ******* *****-*************** ************ ****** ******** **************** | ******** ******* *****-*************** ************ ****** ******** **************** | ******** ******* *****-*************** ************ ****** ******** **************** | ******** ******* *****-*************** ************ ****** ******** **************** | ******** ******* *****-*************** ************ ****** ******** **************** | *****-*************** ************ ****** ******** **************** ** *** *** ***** | ******** ******* *****-*************** ************ ****** ******** **************** | ******* ** ************* ***** *************** ************ ***** * ****-*** **** | ******** ******* *****-*************** ************ ****** ******** **************** | ******** ******* *****-*************** ************ ****** ******** **************** | ******** ******* *****-*************** ************ ****** ******** **************** | ******** ******* *****-*************** ************ ****** ******** **************** | ******** ******* *****-*************** ************ ****** ******** **************** | ******** ******* *****-*************** ************ ****** ******** **************** | ******** ******* *****-*************** ************ ****** ******** **************** | ******** ******* *****-*************** ************ ****** ******** **************** | ******** ******* *****-*************** ************ ****** ******** **************** | ******** ******* *****-*************** ************ ****** ******** **************** | ******** ******* *****-*************** ************ ****** ******** **************** | ******** ******* *****-*************** ************ ****** ******** **************** | ******** ******* *****-*************** ************ ****** ******** **************** | ******** ******* *****-*************** ************ ****** ******** **************** | ******** ******* *****-*************** ************ ****** ******** **************** | ******** ******* *****-*************** ************ ****** ******** **************** | ******** ******* *****-*************** ************ ****** ******** **************** | ******** ******* *****-*************** ************ ****** ******** **************** | *****-*************** ************ ****** ******** **************** ** *** *** ***** | *****-*************** ************ ****** ******** **************** ** *** *** ***** |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|